Rice Hall James & Associates, LLC Maxcyte, Inc. Transaction History
Rice Hall James & Associates, LLC
- $1.66 Billion
- Q4 2024
A detailed history of Rice Hall James & Associates, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 263,833 shares of MXCT stock, worth $1.15 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
263,833Holding current value
$1.15 Million% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding MXCT
# of Institutions
125Shares Held
66MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$35.6 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$35.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$25.1 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$21.9 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$21 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $442M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...